IQGAP3 and prostate carcinoma: IQGAP3 has been shown to govern cell proliferation and migration [36] and has been certified to exhibit high expression in some cancers, such as breast cancer, lung cancer, prostate cancer, kidney cancer, liver cancer, and colorectal cancer [37].